INTRODUCTION
Covalent modification of proteins with phosphatidylinositol (PI) was first suggested as a novel mechanism of membrane attachment when it was found that PI-specific phospholipase C (PI-PLC) could release alkaline phosphatase from tissue slices [1] [2] [3] [4] [5] . Subsequent compositional analysis of Trypanosoma brucei variant surface glycoprotein (VSG) [6, 7] , Torpedo acetylcholinesterase [8] , erythrocyte acetylcholinesterase [9] and rat brain Thy-l [10] revealed that carbohydrates and ethanolamine were also components ofthe membrane anchor. These findings led to the conclusion that these proteins were attached to the cell surface by a glycosylphosphatidylinositol (GPI) anchor. Since then, over 100 proteins have been found to be GPI-anchored (see [11] [12] [13] for reviews). These proteins exist in all eukaryotic species including parasites, Drosophila, yeast and mammals. The functions of the GPI-anchored proteins are also diverse, ranging from enzymes, coat proteins and cell-adhesion molecules to receptors.
The initial studies of both GPI structure and biosynthesis were done with African trypanosomes. Because GPI-anchored VSG represents approximately 10% of the total cellular protein in this parasite [14] , GPI biosynthesis is very active and GPI precursors and mature anchors are abundant. In vivo radiolabelling studies in which GPI was found associated with VSG within 1 min after translation of the protein established that the glycolipid core is pre-assembled and transferred en bloc to newly synthesized proteins in the endoplasmic reticulum (ER) [15, 16] . The isolation and structural elucidation of candidate GPI precursors [17] [18] [19] [20] as well as studies with isolated trypanosome membranes have established that the glycolipid is synthesized by the sequential addition of the predicted carbohydrates to PI [21] [22] [23] .
Although GPI-anchored proteins are not as abundant in yeast and mammalian cells as in parasites, the availability of mutants defective in GPI biosynthesis has made these species invaluable for the study of this pathway. These mutants are listed in Table  1 . Particularly useful have been a set of lymphoma cell mutants deficient in the surface expression of the GPI-anchored T-cell antigen Thy-1. These mutants, which were isolated using complement-mediated lysis by Dr. Robert Hyman [24, 25] , fall into six complementation groups. The Thy-I protein is produced normally by these cells but is not expressed on the cell surface because of defects in either an enzyme or another component required for biosynthesis of the GPI anchor [26, 27] .
Our current understanding of the biosynthetic pathway for GPI membrane anchors obtained from studies in parasites, yeast and mammalian cells will be discussed in this review. The aspects of this process which are particular for only one or two of these species will also be considered. Because structure and biosynthesis are intimately related, the former will also be discussed. However, the coverage of this topic is not meant to be comprehensive and the reader is referred to recent reviews by McConville and Ferguson [12] , Ferguson [28, 29] , Englund [30] and Lublin [31] for further information on GPI structure as well as other topics such as the attachment of the membrane anchor to protein and its function in various cellular processes. 
GPI STRUCTURE
Despite the diversity in the eukaryotic organisms in which they are found and the function of the proteins which they modify, all GPI membrane anchors have a common core structure which is illustrated in Figure 1 . A myo-inositol-containing lipid, usually PI, anchors the GPI in the cell membrane. Unacetylated glucosamine (GlcN), which occurs infrequently in eukaryotic biomolecules, is attached in an al-6 linkage to the inositol. Three mannoses (Man) are then attached through different linkages to form a linear trisaccharide attached to the GlcN residue in an al-4 linkage. Finally, the phosphate of phosphoethanolamine is attached to the 6-position of the third mannose. This glycan, consisting of ethanolamine-PO4-6Manal-2Manal-6Manacl-4GlcNa.l-6myo-inositol, is attached to the C-terminus of a protein by a peptide bond involving the amine of the phosphoethanolamine.
The GPI core is decorated with accessory carbohydrates and phosphoethanolamines that extend from the mannoses and vary with the protein to which it is attached and the tissue or organism in which it is expressed. The extra carbohydrates identified in protein-linked GPI anchors include mannose, glucose, galactose (Gal), N-acetylgalactose, N-acetylneuraminic acid and N-acetylglucosamine (GlcNAc). Comparison of the kinetics of addition of the GPI anchor (t2 of < 1 min) [15, 16] and at least some of the galactoses (t1 of 15 min) [32] with trypanosome VSG suggests that the side-chain carbohydrates are added after transfer of the GPI anchor to the protein [33] . Consistent with this conclusion, endogenous VSG has been shown to be a substrate for agalactosylation by UDP-['4C]Gal in a cell-free trypanosomal system [34] . However, these membranes have also been shown to Figure 1 The GPI core
The conserved GPI core found in all eukaryotic organisms is shown. No structural detail is provided for the lipid portion of the glycolipid because of the variability noted in the text (see 'GPI Structure' section). Abbreviations: Etn, ethanolamine; Ins, inositol. galactosylate a hydrophobic thioglycoside [Manal-6Manal-S-(CH2)7-CH3] that is homologous to a portion of the mature GPI anchor [35] . Glycosylated GPI precursors (galactosylated in trypanosomes [36] and GlcNAc-modified in Toxoplasma gondii [37] ) that arise from modification of the GPI core rather than from degradation of protein-attached GPI anchors have also been found. Therefore the possibility that at least some of the accessory carbohydrates are added to GPI before transfer to protein cannot be ruled out. The addition of extra ethanolamine. phosphates occurs during the biosynthesis of the GPI core in mammalian cells [38] [39] [40] [41] [42] . Whether the resulting GPI precursors containing two or three ethanolamine phosphates can be transferred to protein is not known. However, it seems likely that these modifications are retained in cases where the proteinattached GPI anchors have accessory ethanolamine phosphates.
Other variations in the GPI structure are found in the inositol lipid portion of the molecule. These are in the nature of the lipid backbone (glycerol versus ceramide), the linkages used for attachment of the hydrocarbon chains (ester versus ether), the number and length of the hydrocarbon chains and whether the inositol ring is modified by an acyl chain. Some of these differences appear to be species-specific, while others change with the developmental stage of the organism. Most species utilize a glycerolipid backbone exclusively in the GPI core. However, a ceramide backbone has been found in the GPI anchors of yeast [43] and Dictyostelium [44] . The fatty acids in Trypanosoma brucei VSG and Torpedo acetylcholinesterase [45] are attached to the glycerol backbone by ester linkages, which are found in most phospholipids. In contrast, an ether linkage is found in the sn-l position of the glycerol backbone of GPI anchors on many other parasitic and mammalian proteins [46] [47] [48] . In many of the parasitic proteins, the GPI anchor is a lyso-lipid with only the alkyl chain in the sn-l position and no acyl chain in the sn-2 position [49, 50] . In most species, there appear to be no rigid requirements for specific fatty acids in GPI. However, both acyl chains in the mature GPI anchor of Trypanosoma brucei VSG are exclusively myristate [45] . The occurrence of the acyl chain on the inositol ring {esterified to the 2-hydroxy group ([51] , A. Treumann, M. R. Lifely, P. Schneider and M. A. J. Ferguson, unpublished work)} is variable. This modification, which renders the GPI anchor resistant to cleavage by PI-PLC [51] [52] [53] , is found on some mammalian GPI anchors [19, 47, 52, 54, 55] and on procyclic acidic repetitive protein (PARP) of the procyclic Trypanosome brucei [56] .
Glycolipids that are structurally related to GPI but are not used as protein membrane anchors have been found in Leishmania parasites. These are lipophosphoglycan (LPG) and glycoinositolphospholipids (GIPLs). Although the early steps in the biosynthetic pathways appear to be shared by GPI [57] ) for further information about LPG and GIPL biosynthesis.
BIOSYNTHESIS OF N-ACETYLGLUCOSAMINYL-PI
In the first reaction of GPI biosynthesis, which is shown in Figure 2 , GlcNAc is transferred from UDP-GlcNAc to PI to form N-acetylglucosaminyl-PI (GlcNAc-PI). This reaction has been studied with cell-free systems using trypanosome membranes [21] [22] [23] , mammalian cell lysates [58, 59] and microsomal fractions [60, 61] , yeast membranes [62] and Toxoplasma gondii membranes [37] . In [58] . Despite the apparent specificity for variations in structure of the inositol lipid portion of the GPI anchor in many species, the available evidence suggests that this is not determined by the selection of particular inositol phospholipids for incorporation into GlcNAc-PI. In yeast, GlcNAc-PI and the other early intermediates in GPI biosynthesis are alkaline-labile [62, 65] , indicating that they contain a glycerolbased inositol phospholipid. Therefore the ceramide backbone present in many of the yeast protein-attached GPI anchors is not introduced during the early steps in the biosynthesis of this glycolipid [66] . In mammalian cells, alkylacyl-PI represents less than 5 0% of the total cellular PI [67] . Therefore tremendous selectivity would be required to introduce the alkyl linkage found in many mammalian GPI anchors during GlcNAc-PI biosynthesis. That there is no such selectivity is suggested by the finding that only 15-20 % of the GlcNAc-PI synthesized by lysates of a normal lymphoma cell line contains the sn-alkyl chain as judged by sensitivity to alkaline hydrolysis [58] . Fur-
Enzymology
Analysis of the GlcNAc-PI biosynthetic capacity of the Thy-ldeficient lymphoma mutants revealed that three of the complementation groups (classes A, C and H) were defective in this reaction [58, 60] . Therefore three separate gene products are required for this reaction in mammalian cells. Three complementing yeast mutants in this reaction have also been isolated ( [69] and P. Orlean, unpublished work), indicating that three gene products are also involved in GlcNAc-PI biosynthesis in this species. While there is no reason to expect any difference in the requirements for this reaction in trypanosomes, the number of gene products involved has not been established in this parasite. cDNAs codings for class A and H genes have been expression cloned using the mutants in these components. The class A cDNA, which has been designated PIG-A, was cloned from a HeLa library using the class A mutant human B lymphoblastoid cell line JY-5 [70] . The protein encoded by this cDNA is 484 amino acids in length with a predicted molecular mass of 62.6 kDa and no homology to any known protein. The PIG-A protein contains no apparent signal peptide sequence and a hydrophobic sequence of 27 residues that is 42 amino acids away from the C-terminus of the protein. This hydrophobic sequence may serve as a transmembrane domain which anchors the PIG-A gene product in the ER membrane. The amino acid sequence deduced from the murine PIG-A cDNA is 88 % identical to that of the human gene product, indicating that this protein is highly conserved [71] . The genomic PIG-A gene has been cloned and found to be at least 17 kb in length and to have six exons [72, 73] . Chromosomal localization studies have established that the PIG-A gene is on the X chromosome [72, 74] . To date, no biochemical studies have been carried out to investigate the role of PIG-A in GlcNAc-PI synthesis.
A cDNA which corrects the class H defect in GPI biosynthesis, designated GPI-H, has been cloned from a human placental library using the Ltk-cell line [75] , which belongs to this complementation group [76] . The protein encoded by this cDNA is 188 amino acids in length and is predicted to have a molecular mass of 21 kDa. Like the PIG-A protein, GPI-H is not related by sequence to any other protein. GPI-H, which contains hydrophilic sequences at the N-and C-termini (30 amino acids each) and a relatively hydrophobic core, is proposed to be a cytosolic protein because there is no signal peptide sequence in the cDNA. However, the activity provided by the class H gene product clearly stays associated with the ER membrane upon subcellular fractionation [61, 63] . If the class H protein does not associate with the membrane itself (which has not been ruled out), it may interact with the class A and/or the class C protein in such a way that it behaves as a membrane-bound protein. The genomic location of GPI-H is on chromosome 12 in the mouse [74] . Because many of the genes on mouse chromosome 12 are located on human chromosome 14, Ware et al. [74] suggest that human GPI-H is located on chromosome 14. As with the class A gene product, no information is available regarding the function of the GPI-H gene product in GPI biosynthesis. Therefore, even though studies of the N-ethylmaleimide inhibition of GlcNAc-PI biosynthesis suggest that there is a cysteine residue at or close to the UDP-GlcNAc binding site [77] , it is not known which of the three gene products contains the affected amino acid or the substrate binding site.
Despite the cloning of two of the three genes required for GlcNAc-PI biosynthesis in mammalian cells, no insight as to why three separate proteins are needed for this reaction has been gained. The finding that GlcNAc-PI biosynthesis occurs on the cytosolic face of the ER [63] eliminates the possibility that one of the gene products is required for the transport of UDP-GlcNAc into the lumen of this organelle. Mixing experiments in which GlcNAc-PI biosynthesis was observed when microsomes from each of the mutants was combined with microsomes from normal cells ruled out the possibility that any of the mutants possessed an inhibitory activity [58] . One possibility that has not been addressed is that a heterotrimeric enzyme catalyses the biosynthesis of GlcNAc-PI. Biochemical complementation using microsomes for three mutants has been unsuccessful, even in the presence of detergent [using levels which do not inhibit this reaction in normal microsomes (H. Zhang and V. L. Stevens, unpublished work)]. This finding is consistent with some association between the three gene products being required that cannot be achieved in vitro. Perhaps this association occurs cotranslationally and is dependent on the proteins having certain conformations that are not present when they are expressed separately. Another possibility is that one or both of the remaining gene products is rapidly degraded when the third is not synthesized. Both of these explanations are compatible with the three gene products forming a heterotrimeric enzyme and can be tested once antibodies against the two cloned proteins are made.
Paroxysmal nocturnal haemoglobinuria (PNH)
PNH is an acquired disease in which patients suffer from haemolytic anaemia because several proteins that protect their blood cells from lysis by the complement system (e.g. decay accelerating factor and CD59) are not properly expressed [78, 79] . The underlying defect in PNH is an inability to synthesize the GPI anchor which normally attaches these proteins to the cell surface [79, 80] . Biochemical studies of T-cells [81] and lymphoblastoid cell lines [82, 83] established that the PNH defect in GPI biosynthesis was in GlcNAc-PI formation. Complementation analysis of these cells with the Thy-l-deficient lymphoma cell mutants revealed that the defect resides in the class A gene [81, 82] . To date, the PIG-A gene has been examined and found to be mutated in 31 Japanese patients ( [72, 84] [88] or by thiol alkylating agents [77] . Preliminary studies indicate that Mg2+ is required for GlcNAc-PI deacetylation in mammalian cells (V. L. Stevens and H. Zhang, unpublished work), but whether this is true in other systems is not clear.
MANNOSE ADDITIONS
After deacetylation of GIcNAc-PI to GlcN-PI, the GPI core is extended by the addition of three mannoses. In trypanosomes, GlcN-PI is the substrate for these additions [21, 23] . In yeast [62] and mammalian cells [89, 90] , an acyl group must be added to the inositol ring of GlcN-PI before the mannoses can be added (see 'Inositol acylation' sections below). Therefore GlcN-PI(acyl) is the substrate for mannose additions in these species. The first mannose is added in an Lxl-4 linkage to the GlcN. The second mannose is then linked cl-6 to the first, and the third is linked xl-2 to the second. In trypanosomes, the pathway for GPI biosynthesis is as expected, with ManGlcN-PI being the substrate for the second mannose addition and Man2GlcN-PI being the substrate for the third mannose addition. In mammalian cells, the pathway appears to be more complicated. Although the sequence of reactions has not yet been established, it appears that an ethanolamine-phosphate residue is added to the first mannose before addition of the second and third mannoses (see 'Phosphoethanolamine addition' section below). Therefore the actual substrates for the second and third mannose additions in mammalian cells have not been established conclusively.
The mannoses of the GPI core can be radiolabelled by adding GDP-[3H]mannose to trypanosome membranes [21, 23] . However, the endogenous donor for the three mannoses is dolicholphosphomannose (Dol-P-Man). The first evidence that Dol-PMan was the source of at least one of the core mannoses came from studies of mutants defective in GPI biosynthesis. Chapman et al. [91] found that the class E Thy-l-deficient lymphoma mutant was unable to synthesize Dol-P-Man. Other mammalian cell [92, 93] and yeast [94] mutants with defects in Dol-P-Man production or utilization are also deficient in GPI biosynthesis. Correction of the defect in the class E mutant by transfection with a yeast Dol-P-Man synthase gene resulted in recovery of GPI biosynthesis [95] . That all three mannoses were donated to the GPI core by Dol-P-Man was established by experiments with trypanosomes in which Menon et al. [96] A number of studies have investigated the ability of mannosamine to affect GPI biosynthesis. This amino sugar inhibits this pathway in mammalian cells [98, 99] , trypanosomes [98, 100] and Leishmania parasites [101] . Some conflicting reports exist about the mechanism of inhibition [102] , but most evidence indicates that mannosamine is incorporated into the GPI core predominantly in the position of the second mannose [99, 100] . Because the position 2 substituent in this mannose analogue is an amine that cannot be used for the addition of the third mannose, the mannosamine-containing glycolipid acts as a competitive inhibitor of this reaction and blocks GPI biosynthesis by a chain termination type of mechanism [100] .
PHOSPHOETHANOLAMINE ADDITION
The biosynthesis of the GPI core is completed by the addition of phophoethanolamine to the 6-hydroxy group of the third mannose residue. [60] . A cDNA that corrects the defect in GPI biosynthesis was expression cloned and found to code for a protein of 219 amino acids [66] . Like the other cDNAs encoding proteins required for GPI biosynthesis, PIG-F is not homologous to any known proteins. The sequence is very hydrophobic, as might be expected for an enzyme which transfers phosphoethanolamine from a membrane-bound donor to a membranebound acceptor. Although the gene for PIG-F has not yet been cloned, it has been localized to chromosome 17 in the mouse [74] .
The addition of the terminal phosphoethanolamine to Man3GlcN-PI is inhibited both in vivo and in vitro in trypanosomes by PMSF [88] . This finding suggests that the phosphoethanolamine transferase has an active-site serine residue which may be used to form a serine-phosphoethanolamine intermediate during the transfer reaction.
UNIQUE ASPECTS OF GPI BIOSYNTHESIS IN TRYPANOSOMES
Two modifications of GPI anchors occur in the bloodstream form of Trypanosoma brucei that either do not occur or happen differently in the procyclic form of this parasite and in other organisms. These are replacement of the fatty acids in the GPI
Figure 3 Fatty acid remodelling in bloodstream trypanosomes
The step-wise exchange of the fatty acids of the newly synthesized GPI core for myristate (shown in red), which occurs in trypanosomes, is illustrated.
with myristic acid and the reversible acylation of the inositol ring.
Fatty acid remodelling
The GPI anchor of VSG has exclusively myristic acid attached in ester linkages in the sn-I and sn-2 positions of the glycerol backbone [45] . However, GPI is initially synthesized by trypanosomes with stearic acid in the sn-I position and a mixture of fatty acids including 18:0, 18:1, 20:4 and 22:6 in the sn-2 position [68] . Therefore the fatty acids must be removed and replaced with myristic acid. This process, which has been termed fatty acid remodelling, was dissected by Masterson et al. [105] using a trypanosomal membrane cell-free system. As shown in Figure 3 , remodelling occurs by the sequential replacement of first the sn-2 fatty acid and then the sn-I fatty acid with myristic acid. The fatty acid donor for both of these reacylation reactions is myristoyl-CoA. During remodelling, the GPI precursor retains at least one acyl chain at all times and can remain membraneassociated. The glycolipid which is normally the substrate for fatty acid remodelling is the phosphoethanolamine-containing GPI core [105] . However, when the addition of the phosphoethanolamine is blocked with PMSF, the Man3GlcN-PI which accumulates is found to undergo this process in vivo [106] .
The reason why trypanosomes require myristic acid in their VSG GPI anchors is not known. However, because the hosts of these parasites do not have this requirement and bloodstream trypanosomes utilize exogenous myristic acid for fatty acid remodelling [107] , this process is a potential target for antitrypanosomal drugs. In fact, several myristic acid analogues have been shown to be toxic to trypanosomes [108, 109] .
A process similar to fatty acid remodelling, called myristate exchange, has been described in trypanosomes [110] . During myristate exchange the fatty acids of VSG-attached GPI (which are already myristic acid) are replaced with myristate donated from myristoyl-CoA. This exchange is thought to occur in a different cellular compartment than fatty acid remodelling and to have some different characteristics. While the function of this exchange of fatty acids is unclear, it has been proposed to be a 'proofreading' mechanism to ensure that the Cu4o fatty acid is in the GPI anchor.
Reversible inositol acylation
The GPI anchor of Trypanosoma brucei VSG is completely sensitive to cleavage by PI-PLC [7] , indicating that it is not inositol-acylated. However, acylated GPI precursors have been detected and characterized in this parasite [19, 21, 23, 111] . The major acylated precursor (referred to as either P3 or glycolipid C) contains all components of the mature GPI core and has been shown to be competent for transfer to VSG in a trypanosomal cell-free system [112] . When first characterized, the role of this acylated precursor was not clear. Initially it was suggested to be an intermediate in the fatty acid remodelling of the trypanosome GPI [105] . However, recent evidence indicates that glycolipid C is not an obligate intermediate in the biosynthesis of GPI in this parasite [106] . Guther et al. [106] have shown that the mature unacylated GPI core continued to be made (both in vivo and in vitro) when synthesis of the acylated precursor was blocked by PMSF. Despite inhibition of its synthesis, glycolipid C was deacylated to form the unacylated core. Therefore these authors speculate that glycolipid C is used as a reservoir for excess mature GPI core that could be mobilized for addition to protein by deacylation if needed.
The enzyme which catalyses inositol acylation is sensitive to inhibition by PMSF [106] and acylates predominantly the phosphoethanolamine-modified GPI precursor (acylated forms of earlier precursors have also been detected [21, 23] ). The acylating enzyme is not responsible for the deacylation of glycolipid C, as this process was not inhibited by PMSF [106] . Radiolabelling studies have shown that the inositol acyl group is predominantly palmitic acid [19] . Field et al. [113] showed by pulse-chase analysis that acylation of the GPI anchor of PARP in procyclic trypanosomes increased during the chase despite removal of [3H]palmitate, indicating that the acyl group was derived from a large metabolic pool. Therefore, rather than being transferred directly from an acyl-CoA, the inositol acyl group appears to be derived from a phospholipid precursor.
UNIQUE ASPECTS OF GPI BIOSYNTHESIS IN YEAST Inositol acylation
The biosynthesis of yeast GPI differs from that of trypanosome The occurrence of an inositol acyl group on the GPI anchor of and mammalian membrane anchors in at least two ways. First, mammalian proteins is variable with cell type [55] . However, the like some precursors found in the other species, many of the GPI majority of the mannose-containing GP1 precursors detected intermediates in yeast are acylated on the inositol ring [65] .
either by metabolically radiolabelling cells or in cell-free systems However, the mechanism involved in this modification appears have this extra acyl group [38] [39] [40] [41] [42] . As in yeast, the finding that to be different in this organism. Second, many of the GPI GlcN-PI(acyl) accumulated in a mutant lymphoma cell line anchors on yeast proteins are ceramide-based rather than (class E) unable to make mannose additions to the GPI core led glycerolipid-based. This variation in structure has also been to the proposal that the acylation of GlcN-PI is the obligatory found in Dictyostelium [44] .
third step in GPI biosynthesis in these cells [89] . That GlcN-PI(acyl) is a substrate for mannose additions has been
Inositol acylation demonstrated by pulse-chase analysis of lymphoma cell microsomes in which the radiolabel in this glycolipid was seen to There is no evidence that the GPI anchors of yeast proteins are decrease and appear in mannose-containing GPI precursors resistant to PI-PLC cleavage. However, inositol-acylated GPI upon addition of GDP-mannose to the incubation [90] . The intermediates have been detected in yeast [65] and the inositol inositol acylation reaction has been studied in vitro and found to acylation reaction has been studied using a cell-free system [62] .
be stimulated by the addition of either CoA or an acyl-CoA [90] .
Unlike trypanosomes, in yeast the acyl group is added to GlcNWhen synthesized in a coupled reaction in which GlcN-PI must PI, the second intermediate in the pathway (see Figure 2 ). This also be made in the same incubation, the acylation of this reaction was found to be stimulated when Although mannose addition to GlcN-PI(acyl) by yeast has not occurred in the absence of ATP, an essential cofactor for acylbeen shown directly, the finding that this acylated GPI interCoA synthesis, indicating that free CoA is the endogenous mediate accumulates in yeast defective in Dol-P-Man synthesis effector of this reaction and that the acyl group is most likely [94] supports the proposal that it is an obligatory intermediate in derived from a phospholipid. Therefore the third step in mamthe pathway [62] .
malian GPI biosynthesis has been proposed to be catalysed by a CoA-dependent transacylase [90] .
Inositol acylation involves the same substrate (GlcN-PI) but [114] . Therefore the exchange reaction must happen at time after GPI addition [116] . PI-PLC resistance only appeared some place other than the ER, the site of GPI biosynthesis.
at later times, suggesting that the GPI transferred to protein was Because only alkaline-sensitive GPI precursors corresponding to unacylated. Therefore the mature GPI core made by mammalian the complete core have been found, the exchange reaction has cells must be deacylated prior to addition to protein. been proposed to occur after the transfer of the glycolipid anchor Alternatively, there could be either independent pathways or free to protein [65] , making this process different than the fatty acid interconversion of acylated and non-acylated GPI precursors remodelling that occurs in trypanosomes. As in the parasite, the which has not been seen because most of the characterization of reason for the exchange of the glycerolipid backbone to a these intermediates has been done in mutant cells which acceramide base in yeast is unknown. However, studies using cumulate these glycolipids [38, 39, 41] , perhaps in non-physioinhibitors of sphingolipid biosynthesis in which yeast are found logical ways. Until precursor-product relationships are estabto make only alkaline-sensitive GPI anchors suggests that the lished between the acylated and non-acylated intermediates, need for ceramide in this glycolipid can be overcome [115] .
which of these mechanisms occurs will not be known.
UNIQUE ASPECTS OF GPI BIOSYNTHESIS IN MAMMALIAN CELLS Addition of extra phosphoethanolamines
Like in yeast, inositol acylation occurs early in GPI biosynthesis The structural analysis of GPI precursors in normal and Thy-lin mammalian cells. However, the current evidence suggests that deficient cell lines has revealed that many of the mannosedifferent types of enzymes catalyse this reaction in the two containing intermediates have extra phosphoethanolamines atspecies. Another modification of the GPI core which occurs tached to the core [38] [39] [40] [41] [42] . The glycolipids characterized include during its assembly in mammalian cells which has not been Etn-P-ManGlcN-PI(acyl), Man(Etn-P)ManGlcN-PI, Man- described in other species is the addition of extra phosphoMan(Etn-P)ManGlcN-PI, Etn-P-ManMan(Etn-P)ManGlcN-Pl ethanolamine to the first and second mannose residues.
and Etn-P-Man(Etn-P)Man(Etn-P)ManGlcN-Pl. The various ways that these intermediates could arise are shown in Figure 4 .
Although there is no evidence that any of these potential GPI precursors are actually intermediates in GPI biosynthesis, the most likely pathway for assembly of the membrane anchor based on the occurrence of the different glycolipids is shown in red in Figure 4 . In this pathway, a phosphoethanolamine is added to ManGlcN-PI(acyl) before addition of the next two mannoses. The phosphoethanolamine attached to the 6-position of the third mannose and which is used for linkage to protein is added next. A third phosphoethanolamine is then added to the second mannose to form a three-mannose, three-phosphoethanolamine GPI precursor. What the linkages of the extra phosphoethanolamines to the mannoses are, and whether the two-or three-phosphoethanolamine-containing precursors are used as protein anchors, is not known. The donor of the two phosphoethanolamines attached to the first two mannoses is not known. The finding that the class F Thy-1-deficient mutant synthesizes the Etn-P-ManGlcN-PI(acyl) precursor demonstrates that different enzymes catalyse the addition of the phosphoethanolamines on the first and third mannoses [38, 39] . Identification of the endogenous donors of the extra phosphoethanolamines and the enzymes involved in these reactions will require further study in mammalian cell-free systems.
TOPOLOGY OF GPI BIOSYNTHESIS
The biosynthesis of GPI and the transfer of this glycolipid to protein occur in the ER [63, 64] . Protease protection experiments have established that the later reaction takes place in the lumen of this organelle [64] . Investigation into the topology of GPI biosynthesis in mammalian cells [63] , Trypanosoma brucei [64, 117] and Leishmania major [1 18 ] has shown that either part or all of this pathway, depending on the species, occurs on the cytosolic face of the ER. The first two GPI intermediates, GlcNAc-PI and GlcN-PI, were > 700O sensitive to hydrolysis by PI-PLC in mammalian cell microsomes and Streptolysin 0-permeabilized cells [63] . Therefore the first two reactions in the pathway in mammalian cells are primarily localized in the cytoplasmic leaflet of the ER. The resistance to P1-PLC cleavage conferred by the inositol acyl group on all the subsequent intermediates in mammalian cells has prevented the localization of the later reactions with this methodology. In trypanosomes, where inositol acylation usually does not occur until biosynthesis of the core is complete, all the GPI intermediates were found to be predominantly on the cytosolic face of microsomal vesicles by P1-PLC sensitivity [64] . Concanavalin A binding of the intermediates with three mannose residues confirmed this localization. Pulse-chase analysis showed that the PI-PLCinsensitive GPI precursors were not metabolized into subsequent intermediates, consistent with the idea that these intermediates had been translocated to the ER lumen and were no longer accessible to the cytosolicly oriented biosynthetic enzymes. The finding that expression of a Trypanosoma brucei GPI-specific phospholipase D on the cytosolic face of the ER in Leishmania major resulted in the loss of ethanolamine-containing GPI precursors led to the conclusion that the later reactions have a similar topology in this parasite as in trypanosomes [118] . While it is apparent that the GPI precursor must be translocated to the lumenal face of the ER before transfer to protein, nothing is known about this process.
REGULATION OF GPI BIOSYNTHESIS
Very little is known about the regulation of GPI biosynthesis in any organism. In bloodstream trypanosomes, inhibition of GPI biosynthesis by up to 900O did not affect the transfer of this glycolipid to VSG [88, 100] . Therefore [42] . These investigators quantified inositol-labelled GPI precursors and proteins in SIA lymphoma cells and found that the amount of radiolabel present in protein was only 16-28 % of that found in the GPI precursors. However, these results may be misleading because it is not known whether the precursors identified in either of these studies represented the glycolipid which is actually transferred to protein.
The second reaction in GPI biosynthesis, the deacetylation of GlcNAc-PI, has been found to be stimulated in vitro in mammalian cells by GTP [61] . This stimulation is specific for the guanosine-containing nucleotide triphosphate and results in an approx. 5-fold acceleration in the initial rate of GlcNAc-PI deacetylation by lymphoma cell microsomes. Guanosine 5'-[ythio]triphosphate completely blocks the stimulation by GTP, indicating that the nucleotide triphosphate must be hydrolysed to affect this reaction. Although the deacetylation of GlcNAc-PI is not expected to require energy, the possibility that GTP is hydrolysed for this purpose has not been ruled out. Alternatively, the stimulation by GTP could reflect a regulatory mechanism that involves a GTP-binding protein and affects the level of GPI precursors synthesized by mammalian cells.
CONCLUSIONS
Our understanding of GPI biosynthesis has expanded tremendously in the last 6 years since the first studies of this pathway were reported. The sequence of reactions and most of the endogenous donors of the anchor components are now fairly well defined in most systems. As the focus of investigation has shifted to specific reactions in the pathway, it has become apparent that there are significant differences in GPI biosynthesis in different species. These differences are well defined between trypanosomes and mammalian cells and have been suggested between yeast and mammalian cells. Therefore specific steps in the GPI biosynthetic pathway are potential targets for anti-parasitic and anti-fungal agents. Future investigation of the enzymes and reaction mechanisms of GPI biosynthesis will facilitate the development of inhibitors which could be used as drugs. These inhibitors may also be useful for elucidating the function of the GPI anchor for various proteins in different species or cell types.
The regulation of GPI biosynthesis is another process for which a greater understanding would provide insight into the significance of GPI anchoring in different cells. Important questions to be addressed are: (1) are the synthesis of GPI and the proteins which become GPI-anchored co-ordinately regulated?; (2) 
